A detailed history of Keeler T Homas Management LLC transactions in Repligen Corp stock. As of the latest transaction made, Keeler T Homas Management LLC holds 5,317 shares of RGEN stock, worth $663,189. This represents 0.26% of its overall portfolio holdings.

Number of Shares
5,317
Holding current value
$663,189
% of portfolio
0.26%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$119.79 - $167.35 $636,923 - $889,799
5,317 New
5,317 $791,000
Q3 2023

Oct 26, 2023

BUY
$138.78 - $176.51 $373,318 - $474,811
2,690 New
2,690 $427,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Keeler T Homas Management LLC Portfolio

Follow Keeler T Homas Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keeler T Homas Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keeler T Homas Management LLC with notifications on news.